MKI67 and breast carcinoma: To establish a mechanism(s) that links altered proliferation gene expression and chemotherapy resistance, we treated 9 different breast cancer cell lines with Dx, an anthracycline (100 nM for 2 days), and measured cell cycle response by staining for markers of cell proliferation (Ki67) and cell cycle arrest (p21).